Pathogen-specific T cell depletion and reactivation of opportunistic pathogens in HIV infection

Trends in Immunology

Volumn 33, Issue 5, 2012, Pages 207-214

  Geldmacher, Christof ^a   Koup, Richard A ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTING CELL; CD4+ T LYMPHOCYTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOCYTE FUNCTION; NONHUMAN; OPPORTUNISTIC INFECTION; PHENOTYPE; REVIEW; T CELL DEPLETION; T LYMPHOCYTE ACTIVATION; TH17 CELL; VIRUS ENTRY;

AIDS VACCINES; ANTIGEN-PRESENTING CELLS; HIV INFECTIONS; HUMANS; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DEPLETION; T-LYMPHOCYTES; VIRUS INTERNALIZATION;

EID: 84859890006     PISSN: 14714906     EISSN: 14714981     Source Type: Journal    
DOI: 10.1016/j.it.2012.01.011     Document Type: Review

References (92)

1. Bronke C., et al. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease. J. Infect. Dis. 2005, 191:873-880.
2. Komanduri K.V., et al. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis. J. Infect. Dis. 2001, 183:1285-1289.
3. Komanduri K.V., et al. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1. Nat. Med. 1998, 4:953-956.
4. Autran B., et al. Positive effects of combined antiretroviral therapy on CD4+ T cell homeostasis and function in advanced HIV disease. Science 1997, 277:112-116.
5. Casazza J.P., et al. Autocrine production of beta-chemokines protects CMV-Specific CD4 T cells from HIV infection. PLoS Pathog. 2009, 5:e1000646.
6. Geldmacher C., et al. Preferential infection and depletion of Mycobacterium tuberculosis-specific CD4 T cells after HIV-1 infection. J. Exp. Med. 2010, 207:2869-2881.
7. Dragic T., et al. HIV-1 entry into CD4+ cells is mediated by the chemokine receptor CC-CKR-5. Nature 1996, 381:667-673.
8. Huang Y., et al. The role of a mutant CCR5 allele in HIV-1 transmission and disease progression. Nat. Med. 1996, 2:1240-1243.
9. Moore J.P., et al. The CCR5 and CXCR4 coreceptors - central to understanding the transmission and pathogenesis of human immunodeficiency virus type 1 infection. AIDS Res. Hum. Retroviruses 2004, 20:111-126.
10. Levy J.A. HIV pathogenesis: 25 years of progress and persistent challenges. AIDS 2009, 23:147-160.
11. Picker L.J., et al. Insufficient production and tissue delivery of CD4+ memory T cells in rapidly progressive simian immunodeficiency virus infection. J. Exp. Med. 2004, 200:1299-1314.
12. Brenchley J.M., et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med. 2004, 200:749-759.
13. Qin S., et al. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 1998, 101:746-754.
14. Nishimura Y., et al. Highly pathogenic SHIVs and SIVs target different CD4+ T cell subsets in rhesus monkeys, explaining their divergent clinical courses. Proc. Natl. Acad. Sci. U.S.A. 2004, 101:12324-12329.
15. Ma C.S., et al. Early commitment of naïve human CD4(+) T cells to the T follicular helper (T(FH)) cell lineage is induced by IL-12. Immunol. Cell Biol. 2009, 87:590-600.
16. Zaunders J.J., et al. Early proliferation of CCR5(+) CD38(+++) antigen-specific CD4(+) Th1 effector cells during primary HIV-1 infection. Blood 2005, 106:1660-1667.
17. Maier R., et al. Kinetics of CXCR4 and CCR5 up-regulation and human immunodeficiency virus expansion after antigenic stimulation of primary CD4(+) T lymphocytes. Blood 2000, 96:1853-1856.
18. Bermejo M., et al. Activation of blood T lymphocytes down-regulates CXCR4 expression and interferes with propagation of X4 HIV strains. Eur. J. Immunol. 1998, 28:3192-3204.
19. Jourdan P., et al. Cytokines and cell surface molecules independently induce CXCR4 expression on CD4+ CCR7+ human memory T cells. J. Immunol. 2000, 165:716-724.
20. Ganesan A., et al. Immunologic and virologic events in early HIV infection predict subsequent rate of progression. J. Infect. Dis. 2010, 201:272-284.
21. Mehandru S., et al. Primary HIV-1 infection is associated with preferential depletion of CD4+ T lymphocytes from effector sites in the gastrointestinal tract. J. Exp. Med. 2004, 200:761-770.
22. Li Q., et al. Peak SIV replication in resting memory CD4+ T cells depletes gut lamina propria CD4+ T cells. Nature 2005, 434:1148-1152.
23. Mattapallil J.J., et al. Massive infection and loss of memory CD4+ T cells in multiple tissues during acute SIV infection. Nature 2005, 434:1093-1097.
24. Holm G.H., Gabuzda D. Distinct mechanisms of CD4+ and CD8+ T-cell activation and bystander apoptosis induced by human immunodeficiency virus type 1 virions. J. Virol. 2005, 79:6299-6311.
25. Soumelis V., et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood 2001, 98:906-912.
26. Brown K.N., et al. Rapid influx and death of plasmacytoid dendritic cells in lymph nodes mediate depletion in acute simian immunodeficiency virus infection. PLoS Pathog. 2009, 5:e1000413.
27. Brenchley J.M., et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. Blood 2008, 112:2826-2835.
28. Hutter G., et al. Long-term control of HIV by CCR5 Delta32/Delta32 stem-cell transplantation. N. Engl. J. Med. 2009, 360:692-698.
29. Ribeiro R.M., et al. Naive and memory cell turnover as drivers of CCR5-to-CXCR4 tropism switch in human immunodeficiency virus type 1: implications for therapy. J. Virol. 2006, 80:802-809.
30. Hawkins R.A., et al. Expression of mucosal homing receptor alpha4beta7 is associated with enhanced migration to the Chlamydia-infected murine genital mucosa in vivo. Infect. Immun. 2000, 68:5587-5594.
31. Wagner N., et al. Critical role for beta7 integrins in formation of the gut-associated lymphoid tissue. Nature 1996, 382:366-370.
32. Arthos J., et al. HIV-1 envelope protein binds to and signals through integrin alpha4beta7, the gut mucosal homing receptor for peripheral T cells. Nat. Immunol. 2008, 9:301-309.
33. Cicala C., et al. The integrin alpha4beta7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:20877-20882.
34. Krzysiek R., et al. Preferential and persistent depletion of CCR5+ T-helper lymphocytes with nonlymphoid homing potential despite early treatment of primary HIV infection. Blood 2001, 98:3169-3171.
35. Biancotto A., et al. HIV-1 induced activation of CD4+ T cells creates new targets for HIV-1 infection in human lymphoid tissue ex vivo. Blood 2008, 111:699-704.
36. Chou C.S., et al. Highly purified CD25- resting T cells cannot be infected de novo with HIV-1. Proc. Natl. Acad. Sci. U.S.A. 1997, 94:1361-1365.
37. Zack J.A., et al. HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 1990, 61:213-222.
38. Maenetje P., et al. A steady state of CD4+ T cell memory maturation and activation is established during primary subtype C HIV-1 infection. J. Immunol. 2010, 184:4926-4935.
39. Eberly M.D., et al. Increased IL-15 production is associated with higher susceptibility of memory CD4 T cells to simian immunodeficiency virus during acute infection. J. Immunol. 2009, 182:1439-1448.
40. Mueller Y.M., et al. IL-15 treatment during acute simian immunodeficiency virus (SIV) infection increases viral set point and accelerates disease progression despite the induction of stronger SIV-specific CD8+ T cell responses. J. Immunol. 2008, 180:350-360.
41. Doitsh G., et al. Abortive HIV infection mediates CD4 T cell depletion and inflammation in human lymphoid tissue. Cell 2010, 143:789-801.
42. Okoye A., et al. Progressive CD4+ central memory T cell decline results in CD4+ effector memory insufficiency and overt disease in chronic SIV infection. J. Exp. Med. 2007, 204:2171-2185.
43. Caruso A.M., et al. Mice deficient in CD4 T cells have only transiently diminished levels of IFN-gamma, yet succumb to tuberculosis. J. Immunol. 1999, 162:5407-5416.
44. Gallegos A.M., et al. Delayed protection by ESAT-6-specific effector CD4+ T cells after airborne M. tuberculosis infection. J. Exp. Med. 2008, 205:2359-2368.
45. Sonnenberg P., et al. How soon after infection with HIV does the risk of tuberculosis start to increase? A retrospective cohort study in South African gold miners. J. Infect. Dis. 2005, 191:150-158.
46. World Health Organization (2008) Frequently asked questions about TB and HIV.
47. Geldmacher C., et al. Early depletion of Mycobacterium tuberculosis-specific T helper 1 cell responses after HIV-1 infection. J. Infect. Dis. 2008, 198:1590-1598.
48. Kalsdorf B., et al. HIV-1 infection impairs the bronchoalveolar T-cell response to mycobacteria. Am. J. Respir. Crit. Care Med. 2009, 180:1262-1270.
49. Waldrop S.L., et al. Determination of antigen-specific memory/effector CD4+ T cell frequencies by flow cytometry: evidence for a novel, antigen-specific homeostatic mechanism in HIV-associated immunodeficiency. J. Clin. Invest. 1997, 99:1739-1750.
50. Glennie S.J., et al. Impaired CD4 T cell memory response to Streptococcus pneumoniae precedes CD4 T cell depletion in HIV-infected Malawian adults. PLoS ONE 2011, 6:e25610.
51. Brenchley J.M., et al. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J. Virol. 2004, 78:1160-1168.
52. DeVico A.L., Gallo R.C. Control of HIV-1 infection by soluble factors of the immune response. Nat. Rev. Microbiol. 2004, 2:401-413.
53. Douek D.C., et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature 2002, 417:95-98.
54. Harari A., et al. Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence. J. Immunol. 2005, 174:1037-1045.
55. Harari A., et al. Phenotypic heterogeneity of antigen-specific CD4 T cells under different conditions of antigen persistence and antigen load. Eur. J. Immunol. 2004, 34:3525-3533.
56. Streitz M., et al. Loss of receptor on tuberculin-reactive T-cells marks active pulmonary tuberculosis. PLoS ONE 2007, 2:e735.
57. Schuetz A., et al. Monitoring CD27 expression to evaluate Mycobacterium tuberculosis activity in HIV-1 infected individuals in vivo. PLoS ONE 2011, 6:e27284.
58. Hammond A.S., et al. Mycobacterial T cell responses in HIV-infected patients with advanced immunosuppression. J. Infect. Dis. 2008, 197:295-299.
59. Samandari T., et al. 6-month versus 36-month isoniazid preventive treatment for tuberculosis in adults with HIV infection in Botswana: a randomised, double-blind, placebo-controlled trial. Lancet 2011, 377:1588-1598.
60. Oni T., et al. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax 2011, 66:669-673.
61. Harari A., et al. Dominant TNF-alpha+ Mycobacterium tuberculosis-specific CD4+ T cell responses discriminate between latent infection and active disease. Nat. Med. 2011, 17:372-376.
62. Pope M., et al. Conjugates of dendritic cells and memory T lymphocytes from skin facilitate productive infection with HIV-1. Cell 1994, 78:389-398.
63. Lore K., et al. Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells. J. Exp. Med. 2005, 201:2023-2033.
64. Fujita H., et al. Human Langerhans cells induce distinct IL-22-producing CD4+ T cells lacking IL-17 production. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:21795-21800.
65. Hoshino Y., et al. Maximal HIV-1 replication in alveolar macrophages during tuberculosis requires both lymphocyte contact and cytokines. J. Exp. Med. 2002, 195:495-505.
66. Wille-Reece U., et al. Toll-like receptor agonists influence the magnitude and quality of memory T cell responses after prime-boost immunization in nonhuman primates. J. Exp. Med. 2006, 203:1249-1258.
67. Mehandru S., et al. Mechanisms of gastrointestinal CD4+ T-cell depletion during acute and early human immunodeficiency virus type 1 infection. J. Virol. 2007, 81:599-612.
68. Cecchinato V., et al. Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques. Mucosal Immunol. 2008, 1:279-288.
69. Brenchley J.M., et al. Microbial translocation is a cause of systemic immune activation in chronic HIV infection. Nat. Med. 2006, 12:1365-1371.
70. Deeks S.G., et al. Immune activation set point during early HIV infection predicts subsequent CD4+ T-cell changes independent of viral load. Blood 2004, 104:942-947.
71. Acosta-Rodriguez E.V., et al. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 2007, 8:639-646.
72. Annunziato F., et al. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 2007, 204:1849-1861.
73. Raffatellu M., et al. Simian immunodeficiency virus-induced mucosal interleukin-17 deficiency promotes Salmonella dissemination from the gut. Nat. Med. 2008, 14:421-428.
74. Adler D.H. The impact of HAART on HPV-related cervical disease. Curr. HIV Res. 2010, 8:493-497.
75. Palefsky J. Human papillomavirus-related disease in people with HIV. Curr. Opin. HIV AIDS 2009, 4:52-56.
76. Carbone A., et al. HIV-associated lymphomas and gamma-herpesviruses. Blood 2009, 113:1213-1224.
77. Chang Y., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
78. Piriou E., et al. Loss of EBNA1-specific memory CD4+ and CD8+ T cells in HIV-infected patients progressing to AIDS-related non-Hodgkin lymphoma. Blood 2005, 106:3166-3174.
79. Gasser O., et al. HIV patients developing primary CNS lymphoma lack EBV-specific CD4+ T cell function irrespective of absolute CD4+ T cell counts. PLoS Med. 2007, 4:e96.
80. Cheynier R., et al. HIV and T cell expansion in splenic white pulps is accompanied by infiltration of HIV-specific cytotoxic T lymphocytes. Cell 1994, 78:373-387.
81. Klatt N.R., et al. SIV infection of rhesus macaques results in dysfunctional T- and B-cell responses to neo and recall Leishmania major vaccination. Blood 2011, 118:5803-5812.
82. Griffin E., et al. Oral mucosal reactivation rates of herpesviruses among HIV-1 seropositive persons. J. Med. Virol. 2008, 80:1153-1159.
83. McKenzie N.D., et al. Women with HIV are more commonly infected with non-16 and -18 high-risk HPV types. Gynecol. Oncol. 2010, 116:572-577.
84. Strickler H.D., et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J. Natl. Cancer Inst. 2005, 97:577-586.
85. Luque A.E., et al. Prevalence of human papillomavirus genotypes and related abnormalities of cervical cytological results among HIV-1-infected women in Rochester, New York. J. Infect. Dis. 2006, 194:428-434.
86. Sahasrabuddhe V.V., et al. Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia. Br. J. Cancer 2007, 96:1480-1483.
87. Coleman N., et al. Immunological events in regressing genital warts. Am. J. Clin. Pathol. 1994, 102:768-774.
88. de Jong A., et al. Human papillomavirus type 16-positive cervical cancer is associated with impaired CD4+ T-cell immunity against early antigens E2 and E6. Cancer Res. 2004, 64:5449-5455.
89. de Jong A., et al. Frequent detection of human papillomavirus 16 E2-specific T-helper immunity in healthy subjects. Cancer Res. 2002, 62:472-479.
90. Woo Y.L., et al. A prospective study on the natural course of low-grade squamous intraepithelial lesions and the presence of HPV16 E2-, E6- and E7-specific T-cell responses. Int. J. Cancer 2010, 126:133-141.
91. Hansen S.G., et al. Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge. Nat. Med. 2009, 15:293-299.
92. Chapman R., et al. Recombinant Mycobacterium bovis BCG as an HIV vaccine vector. Curr. HIV Res. 2010, 8:282-298.